https://rjrindex.com/articles/drug-releasing-intravesical-floating-technology-drift-for-administration-of-sequential-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-in-the-diagnosis-and-prognosis-of-upper-tract-urothelial-carcinoma-a-compre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survivorship-outcomes-of-stage-i-testis-cancer-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-a-computational-histology-artificial-intelligence-chai-prognostic-biomarker-in-muscl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synergistic-efficacy-of-gedatolisib-and-darolutamide-in-prostate-cancer-to-overcome-resistance-to-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-assessment-during-prostate-cancer-radionuclide-therapy-updated-fact-rnt-psychometri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rndo-564-001-a-first-in-human-phase-11b-study-of-rndo-564-a-bispecific-antibody-for-the-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neoadjuvant-chemotherapy-on-outcomes-of-bladder-preserving-chemoradiotherapy-in-muscle-inv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-care-preferences-in-penile-cancer-patients-shifting-patterns-and-disparities-over-two-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-platinum-based-neoadjuvant-chemotherapy-with-gemcitabine-at-800-mgm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/izabright-bladder01-a-randomized-open-label-phase-23-trial-of-izalontamab-brengitecan-iza-bren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-profile-related-evidence-determining-individualized-cancer-therapy-i-predict-n-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-parallel-group-phase-ii-study-neoteric-of-atezolizumab-with-or-without-tiragolumab-afte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disitamab-vedotin-plus-pd-1-inhibitors-as-neoadjuvant-therapy-for-cisplatin-ineligible-muscle-invasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-evaluation-of-treatment-patterns-following-cabozantinib-treatment-for-advanced-renal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-major-adverse-cardiac-events-in-men-with-prostate-cancer-receiving-androgen-deprivatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pelvic-lymph-node-risk-stratification-in-prostate-cancer-a-machine-learning-approach-toward-a-predi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/poster-evaluating-the-impact-of-virtual-peer-led-support-groups-on-prostate-cancer-survivorship-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/noninvasive-fragmentomic-profiling-of-plasma-cell-free-dna-cfdna-in-metastatic-prostate-cancer-mp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discrepancies-in-the-administration-of-sequential-therapies-for-metastatic-renal-cell-carcinoma-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-genomic-analysis-of-chemerin-in-prostate-cancer-pca-and-correlation-with-markers-of-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-glp1-receptor-agonists-on-severity-of-prostate-cancer-at-diagnosis-a-propensity-score-wei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-prostate-cancer-a-time-series-analysis-of-age-stratified-trends 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-evaluation-of-sexual-function-over-5-years-in-patients-with-localized-prostate-cancer-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-her2-expression-in-prostate-cancer-compared-with-other-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-cabazitaxel-following-177lu-psma-617-lupsma-in-patients-with-metastatic-castration-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-from-core-008-cohort-a-phase-2-study-of-intravesical-cretostimogene-grenadenorepvec-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-outcomes-of-advanced-prostate-cancer-among-black-compared-to-white-men-in-the-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-characterization-of-prostate-cancer-in-patients-with-hiv-infection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-treatment-intensification-in-metastatic-hormone-sensitive-prostate-cancer-instituti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatially-mapping-the-prostate-cancer-tumor-microenvironment-to-reveal-immune-cell-drivers-of-aggres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-repair-gene-alterations-and-outcomes-with-enfortumab-vedotin-plus-pembroliz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multidimensional-profiling-of-clinical-trial-cohorts-and-the-characterization-of-radiotherapyimmuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-clinical-outcomes-and-genomic-predictors-of-psma-petct-guided-cytoreductive-progression-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dissecting-the-tumor-microenvironment-of-advanced-urothelial-carcinoma-pre-and-post-enfortumab-vedot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imtapi-loss-in-penile-squamous-cell-carcinoma-penscc-a-genomic-landscape 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-response-after-neoadjuvant-therapy-in-renal-cell-carcinoma-using-irrvt-criteria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-pre-operative-circulating-tumor-dna-ctdna-status-with-clinicopathologic-characteris 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncological-outcomes-of-primary-retroperitoneal-lymph-node-dissection-in-patients-with-clinical-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-time-to-recurrence-after-radical-cystectomy-for-bladder-cancer-impact-subsequent-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-epidural-analgesia-vs-combined-intravenous-patient-controlled-analgesia-and-transversus-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-derived-primary-prostate-cancer-epithelial-cultures-for-studying-prostate-cancer-cell-evolut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-intraoperative-frozen-section-analysis-neurosafe-on-oncologic-and-functional-outcomes-af 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-neoadj-gemcitabine-intravesical-system-gem-idrs-plus-cetrelimab-cet-or-cet-alone-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-germline-testing-in-localized-prostate-cancer-prevalence-of-germline-variants-and-associ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examination-of-decipher-prostate-genomic-classifier-in-patients-with-de-novo-metastatic-disease-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-tivozanib-in-metastatic-renal-cell-carcinoma-in-a-diverse-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urologist-level-variation-in-androgen-deprivation-therapy-intensification-in-patients-with-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-safety-of-first-line-1l-systemic-regimens-for-locally-advanced-or-metastatic-uroth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-age-on-outcomes-in-metastatic-non-clear-cell-renal-cell-carcinoma-mnccrcc-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-blinded-validation-of-a-urinary-cfdna-methylation-assay-in-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-imtapi-loss-in-liquid-biopsies-from-patients-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-mutated-ib2mi-an-immune-related-gene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-bleomycin-shortage-on-real-world-outcomes-in-germ-cell-tumors-a-multicenter-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-arpi-utilization-patterns-and-outcomes-in-metastatic-castration-sensitive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-systemic-therapies-after-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-rankl-inhibitors-versus-bisphosphonates-in-metastatic-prostate-cancer-with-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-loss-of-kdm6a-mediated-genomic-instability-and-metabolic-reprogramming-on-response-to-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-and-molecular-determinants-of-response-in-penile-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacokinetics-and-dosimetry-of-lutetium-lu-177-zadavotide-guraxetan-in-patients-with-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-cancer-organ-tropism-in-mcrpc-patients-using-triple-tracer-pet-imaging-radiomics-clusteri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-study-of-enhanced-ar-blockade-with-enzalutamide-in-high-risk-patients-with-bioc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gemcitabine-intravesical-system-gem-idrs-in-combination-with-cetrelimab-cet-versus-chemoradiothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-utilization-and-hospitalization-outcomes-among-patients-with-renal-cell-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-mortality-from-bladder-cancer-with-chronic-kidney-disease-in-the-united-states-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/divergent-biology-and-outcomes-of-somatic-transformations-sm-in-germ-cell-tumors-gct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-barriers-to-adopting-first-line-standards-of-care-in-lamuc-a-community-practice-informe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-safety-and-tolerability-of-tara-002-in-patients-with-bcg-naive-and-unresponsive-high-grade-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arto-trial-nct03449719-long-term-overall-survival-analysis-from-a-randomized-phase-ii-trial-testi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-bone-modifying-agents-in-metastatic-hormone-resistant-prostate-cancer-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-genomic-classification-and-clinical-characteristics-as-a-predictor-of-survival-in-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-empower-trial-evaluating-a-home-based-physical-activity-program-pap-with-the-exerciserx-digit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-ancillary-multiparametric-mri-features-in-pi-rads-3-prostate-lesions-and-their-associa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-cabozantinib-formulation-with-reduced-pharmacokinetic-variability-and-the-potential-to-impro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-ultra-sensitive-whole-genome-circulating-tumor-dna-detection-to-predict-early-recurrence-in-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-metabolic-syndrome-and-treatment-outcomes-in-metastatic-prostate-cancer-a-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-omaha-u01-substudy-01a-oral-cyp11a1-inhibitor-opevesostat-alone-or-in-combination-with-ot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-survival-and-treatment-outcomes-in-malignant-spermatic-cord-tumors-a-two-decade-popula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conventional-dose-chemotherapy-as-first-salvage-in-germ-cell-tumors-outcomes-from-an-ibero-american 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-prostate-cancer-mortality-after-the-2012-uspstf-psa-guideline-comparisons-with-kidney-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-institution-analysis-of-outcomes-with-first-line-ipilimumab-and-nivolumab-for-514-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-characteristics-of-advanced-urothelial-carcinoma-uc-patients-pts-who-fail-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-analysis-from-the-prospective-pt0-study-of-systematic-endoscopic-evaluation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-blind-spots-in-rezilient-1-does-post-platinum-zipalertinib-address-needs-in-epidermal-gro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-analysis-from-the-phase-2-litespark-013-study-of-2-different-belzutifan-bel-doses-in-par 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kim-1-levels-in-papillary-renal-cell-carcinoma-from-the-calypso-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-in-intermediate-risk-biochemically-recurrent-prostate-cancer-bcr-the-national-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-nivolumab-ipilimumab-and-cabozantinib-in-patients-with-brain-metastases-from-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-with-radium-223-in-metastatic-castration-resistant-prostate-cancer-us-patient-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-patients-pts-with-metastatic-castration-resistant-prostate-cancer-mcrpc-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimas-a-phase-ii-randomized-decentralized-de-escalation-trial-in-patients-pts-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-outcomes-from-a-randomized-controlled-trial-comparing-mri-guided-transurethral-ultraso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/angelica-herbal-supplement-agn-cogniq-acute-dose-safety-and-pharmacokinetics-pk-dose-response-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimated-net-benefit-of-talazoparib-tala-enzalutamide-enza-for-patients-pts-with-mcrpc-usin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toripalimab-in-patients-with-previously-treated-advanced-upper-tract-urothelial-carcinoma-a-subgrou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carpet-trial-a-phase-ii-trial-evaluating-trastuzumab-deruxtecan-in-metastatic-castration-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-efficacy-and-patient-experience-with-neoadjuvant-cabozantinib-for-locally-advanced-renal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-phase-ii-study-of-first-line-modified-folfirinox-in-patients-with-advanced-urachal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promoter-methylation-of-aquaporin-1-as-a-prognostic-biomarker-in-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-of-new-perioperative-treatment-regimens-for-muscle-invasive-bladder-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/twenty-five-years-of-bladder-cancer-mortality-in-the-us-1999-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-digital-ki67-based-risk-modeling-on-prognostic-precision-in-non-muscle-invasive-bladder-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hormone-therapy-use-and-duration-with-post-operative-radiotherapy-for-recurrent-prostate-cancer-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swog-s1602-a-phase-iii-randomized-trial-to-evaluate-bcg-strain-differences-and-priming-with-intrade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-utility-of-lactate-dehydrogenase-in-patients-with-metastatic-seminoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vertebral-surgery-in-the-management-of-complex-postchemotherapeutic-retroperitoneal-lymph-node-disse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-one-time-sensitive-screening-intervention-on-prostate-cancer-mortality-the-sthlm3-rando 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-deprivation-therapy-and-radiotherapy-with-or-without-cabazitaxel-in-very-high-risk-localize 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-assessment-of-patient-reported-quality-of-life-and-mental-health-during-active-surveill 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-adolescent-and-young-adult-renal-cell-carcinoma-in-the-modern-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-participants-pts-with-bacillus-calmette-guerin-bcg-unresponsive-high-risk-non-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-and-outcomes-among-patients-with-metastatic-castrate-resistant-prostate-cancer-with-an-ar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trimodal-therapy-versus-radical-cystectomy-in-muscle-invasive-bladder-cancer-the-overlooked-influen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/forager-2-a-randomized-phase-3-study-evaluating-the-efficacy-and-safety-of-vepugratinib-combined-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bladder-cancer-bc-screening-in-un-affected-caucasian-ancestry-family-members-of-patients-who-teste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-retroperitoneal-lymph-node-dissection-in-patients-with-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-radiomic-skeletal-muscle-features-on-prostate-t1-weighted-mri-with-major-adverse-card 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-risk-evaluation-in-men-with-prostate-cancer-study-care-pc-pilot-study-to-assess-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-sensitive-molecular-residual-disease-detection-via-tumor-informed-whole-genome-sequencing-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-urethral-squamous-cell-carcinoma-insights-and-outcomes-from-a-27-year-institutional-experie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-tryptophan-serotonin-kynurenine-pathways-on-immune-landscape-and-survival-in-clear-cell-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-models-combining-sup68sup-ga-psma-pet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-obesity-on-biphasic-immune-remodeling-of-cd45-circulating-cells-during-androgen-deprivat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-urinary-detection-of-fgfr-alterations-to-guide-fgfr-inhibitor-therapy-in-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/parallel-liquid-biopsy-analysis-of-mir-371a-3p-and-cell-free-dna-in-testicular-germ-cell-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-an-anti-pd-l1il-15-variant-fusion-protein-sim0237-in-bcg-unresponsive-high-ris 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-prior-5-a-reductase-inhibitor-exposure-with-ici-benefit-in-metastatic-rcc-multicentr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-evidence-based-first-line-therapy-for-metastatic-urothelial-carcinoma-a-quality-improv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-maximal-transurethral-resection-before-neoadjuvant-chemotherapy-on-pathological-response-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rna-based-liquid-biopsy-testing-of-urine-to-predict-pathological-complete-response-to-radiomolecular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-gain-trial-gemcitabine-alternating-with-intravesical-bcg-randomized-against-bcg-alone-for-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inclusion-of-patients-from-latin-america-in-pivotal-trials-in-genitourinary-gu-and-cutaneous-malig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-of-long-term-survivors-with-metastatic-castration-resistant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-diagnostics-in-prostate-cancer-treatment-predict-a-phase-2-multi-arm-biomarker-based-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-utilization-in-metastatic-renal-cell-carcinoma-mrcc-following-implementation-of-a-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-affecting-racial-impact-in-testicular-cancer-outcomes-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/solace-a-phase-1-pharmacokinetic-dosimetry-safety-and-dose-optimization-study-for-a-single-dose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consolidate-a-phase-iii-study-of-radiotherapy-combined-with-enfortumab-vedotin-ev-for-locally-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/activity-and-biomarker-analyses-with-casdatifan-cas-a-next-generation-hif-2a-inhibitor-in-refrac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-depth-and-durability-of-response-in-patients-pts-with-previously-untreated-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-dll3-t-cell-engager-gocatamig-in-participants-pts-with-neuroendocrine-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-positive-ureteral-margin-on-upper-tract-recurrence-after-radical-cystectomy-for-bladder-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-radiotherapy-and-interventional-therapy-for-adrenal-oligometastases-a-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ferroptosis-suppression-and-its-association-with-chemoradiotherapy-resistance-in-muscle-invasive-bla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-outcomes-associated-with-enzalutamide-enza-vs-apalutamide-apa-in-metastatic-cast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-monitoring-of-fgfr3-altered-metastatic-urothelial-cancer-treated-with-dabogratinib-formerly-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-peripheral-blood-neutrophillymphocyte-ratio-nlr-dynamics-to-predict-primary-refractory-dise 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-sensitive-whole-genome-sequencing-based-molecular-residual-disease-detection-in-resectable-ren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ivhli-wild-type-clinically-advanced-clear-cell-renal-cell-carcinoma-ccrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunological-clustering-from-peripheral-blood-to-define-prognosis-and-t-cell-exhaustion-profiles-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surveillance-of-patients-with-complete-response-following-first-line-chemotherapy-for-germ-cell-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-non-luminal-subtype-with-overall-survival-in-high-risk-non-muscle-invasive-bladder-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-zanzalintinib-for-patients-with-advanced-urothelial-carcinoma-following-prior-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-flotufolastat-f18-psma-pet-scans-to-enhance-detection-of-prostate-cancer-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-predictors-of-sipuleucel-t-sip-t-outcomes-in-men-with-metastatic-castration-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-rx-patterns-and-survival-outcomes-in-patients-with-metastatic-chromophobe-renal-cell-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profiling-bcraness-phenotype-in-public-prostate-cancer-datasets-without-homologous-repair-gene-mutat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-phase-ii-study-of-adaptive-combination-immunotherapy-with-vegfr-tki-for-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-and-trends-in-the-in-hospital-mortality-for-malignant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-duration-of-immune-checkpoint-inhibitor-therapy-in-genitourinary-cancers-a-systematic-revie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-resistant-subclones-as-drivers-of-progression-in-aggressive-variant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-dll3cd3-t-cell-engager-obrixtamig-in-patients-with-genitourinary-extrapu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-treatment-patterns-in-patients-with-advanced-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-impact-of-rdi-on-outcomes-in-patients-treated-with-enfortumab-vedotin-pembrolizumab-combin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physician-perspectives-on-the-implementability-of-a-cardiovascular-risk-score-for-prostate-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-rx-patterns-and-outcomes-with-second-line-2l-therapy-in-patients-pts-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/partial-nephrectomy-pn-versus-ablative-therapies-at-for-t1a-clear-cell-renal-cell-carcinoma-ccr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intratumoral-mature-tlss-to-predict-response-to-ici-rechallenge-in-non-clear-cell-renal-cell-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-receptor-pathway-inhibitors-triplet-therapy-araat-real-world-outcomes-in-metastatic-horm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-and-predictors-of-online-cancer-information-seeking-among-urological-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-spatial-transcriptomics-to-analyze-the-molecular-landscape-of-tuberous-sclerosis-complex-asso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/marking-techniques-for-target-lymph-nodes-in-node-positive-breast-cancer-treated-with-neoadjuvant-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/selective-bladder-preservation-after-neoadjuvant-zanidatamab-combined-with-tislelizumab-and-chemothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-the-risk-of-prostate-cancer-metastasis-at-diagnosis-in-the-va-health-care-system-from-ha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/harnessing-caregiver-support-to-improve-shared-decision-making-in-metastatic-prostate-cancer-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-radium-223-therapy-in-combination-with-enzalutamide-for-metastatic-castration-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-baseline-serum-igg-in-metastatic-clear-cell-renal-cell-carcinoma-treated-with-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-comprehensive-population-wide-genomic-testing-in-metastatic-prostate-cancer-mpca-a-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-provocative-analysis-of-first-line-strategies-in-advanced-urothelial-carcinoma-reconstructed-indi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-circulating-tumor-dna-ctdna-and-itp53i-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-treatment-acquired-homozygous-losses-homozygous-deletions-of-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-care-qoc-measures-among-patients-with-recurrent-papillary-only-bacillus-calmette-gueri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extended-multi-centre-review-of-adjuvant-pembrolizumab-for-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-with-single-agent-erdafitinib-erda-in-patients-pts-with-advanced-ur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histopathologic-and-spatial-transcriptomic-analyses-of-en-bloc-resections-of-de-novo-and-recurrent-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expansion-and-characterization-of-tumor-infiltrating-lymphocytes-from-primary-and-metastatic-immune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-socioeconomic-disadvantage-using-ai-analysis-of-ct-imaging-in-kidney-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-multicenter-development-and-external-validation-of-a-narrow-band-imaging-based-predictio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-belzutifan-in-patients-with-metastatic-clear-cell-renal-cell-carcinoma-mccrc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-overall-survival-with-evolving-systemic-therapies-for-metastatic-non-clear-cell-rcc-an-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subclinical-hepatic-injury-and-risk-of-nonalcoholic-steatohepatitis-after-adjuvant-systemic-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-the-preoperative-de-ritis-ratio-and-its-association-with-sarcopenia-in-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-for-stage-iv-non-small-cell-lung-cancer-without-driver-alterations-asco-living-guideline-2-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-retroperitoneal-lymph-node-dissection-for-clinical-stage-iiab-metastatic-seminoma-a-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blood-and-urine-based-ctdna-profiling-and-monitoring-in-bladder-carcinoma-in-situ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/micro-ultrasound-compared-with-mri-targeted-biopsy-in-detecting-clinically-significant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hemoglobin-albumin-lymphocyte-and-platelet-halp-score-as-a-prognostic-indicator-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-her2-and-nectin4-expression-with-clinical-outcomes-in-patients-pts-with-advanced-ur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-findings-and-clinical-outcomes-after-immune-checkpoint-blockade-in-renal-cell-carcinoma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/family-awareness-of-genetic-risk-in-affected-caucasian-ancestry-members-with-bladder-cancer-bc-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-utilization-among-patients-pts-with-metastatic-hormone-sensitive-prostate-cancer-mhspc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-early-achievement-of-ultra-low-psa-levels-with-radiologic-progression-free-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-operative-pelvic-lymph-node-radiation-therapy-in-lymph-node-positive-prostate-cancer-and-mortal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-profiling-of-residual-cancer-burden-after-neoadjuvant-hormonal-therapy-guides-subtype-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-luxdegalutamide-in-combination-with-abiraterone-in-adult-patients-with-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-dose-escalation-study-of-ktx-2001-an-nsd2-inhibitor-alone-and-in-combination-with-darolut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-monitoring-of-derived-neutrophil-to-lymphocyte-ratio-dnlr-as-a-predictive-biomarker-of-benef 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-level-trends-in-radiation-treatment-of-low-risk-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-frailty-and-its-drivers-in-bladder-cancer-using-machine-learning-derived-vulnerabilit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-of-bladder-and-upper-tract-micropapillary-variant-urothelial-carcinoma-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toward-noninvasive-genomic-profiling-in-muscle-invasive-bladder-cancer-using-quantitative-ct-texture 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validity-of-foundationone-cdx-assay-to-identify-ihrri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-bladder-to-upper-urinary-tract-unveiling-the-epidemiological-dynamics-of-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-effectiveness-and-safety-of-avelumab-first-line-maintenance-1lm-in-locally-advanced-or-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup225sup-acac-aky-1189-a-nectin-4-targeted-radioph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changes-in-ctcae-v6-effect-on-dose-escalation-and-dose-limiting-toxicity-with-repeat-analysis-of-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-grade-group-1-prostate-cancer-with-extraprostatic-extension-resu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prolaris-test-on-diagnostic-biopsy-for-localized-prostate-cancer-prognosis-across-risk-groups-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-risk-with-androgen-receptor-pathway-inhibitors-real-world-evidence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-trial-of-nivolumab-relatlimab-plus-ipilimumab-vs-nivolumab-plus-ipilimumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-toxicity-profiles-of-next-generation-androgen-receptor-pathway-inhibitors-in-the-geria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blind-spots-in-rezilient-1-does-post-platinum-zipalertinib-address-needs-in-epidermal-growth-factor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-pembrolizumab-and-enfortumab-vedotin-in-variant-histology-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cyto-kik-a-phase-ii-trial-of-cytoreductive-surgery-in-kidney-cancer-plus-immunotherapy-nivolumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-pasritamig-pas-docetaxel-doce-in-participants-with-metastatic-castratio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psma-pet-versus-conventional-imaging-in-metastatic-prostate-cancer-evaluation-of-disease-volume-cla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-treatment-patterns-in-patients-pts-with-metastatic-renal-cell-carcinoma-mrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-outcomes-of-patients-pts-with-small-cell-or-neuroendocrine-carcinoma-scne-of-the-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-sup177sup-lu-psma-617-in-neuroendocrine-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intermittent-fasting-in-prostate-cancer-patients-receiving-androgen-deprivation-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-cfchip-seq-to-predict-cell-surface-target-expression-in-neuroendocrine-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ccl21-as-a-treatment-linked-prognostic-biomarker-in-metastatic-castration-resistant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-assessment-of-deletions-in-coq-biosynthesis-pathway-genes-associated-with-poor-prognosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histologic-predictors-of-clinically-significant-biochemical-recurrence-and-psa-kinetics-after-radica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardio-kidney-metabolic-syndrome-and-prostate-cancer-prognostic-significance-of-higher-stages-for-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-racial-patterns-in-prostate-cancer-stage-migration-following-uspstf-psa-screening-polic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-immune-checkpoint-inhibitor-combination-therapies-by-metastatic-site-in-meta-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-pt-preferences-for-treatment-tx-of-non-metastatic-hormone-sensitive-prostate-cancer-nmh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-first-line-1l-avelumab-axitinib-ave-axi-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sasanlimab-plus-bacillus-calmette-guerin-in-bcg-naive-high-risk-non-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-data-from-uplift-phase-iii-study-of-cdk46-inhibition-with-abemaciclib-to-upregulate-psma-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-from-the-phase-2-trial-of-abiraterone-olaparib-or-abiraterone-olaparib-in-first 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empower01-a-phase-ii-study-of-zanidatamab-combined-with-bacillus-calmette-guerin-bcg-in-her2-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/autoantibody-aab-profiling-in-metastatic-cisplatin-ineligible-metastatic-urothelial-carcinoma-muc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-circulating-tumor-dna-ctdna-in-the-detection-of-residual-disease-and-recurrence-for-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-and-pathologic-responses-to-neoadjuvant-androgen-receptor-pathway-inhibitor-arp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-resource-utilization-hcru-and-costs-among-us-patients-pts-with-locally-advanced-or-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-screening-in-a-geriatric-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relevance-of-fresh-frozen-sections-ffs-for-carcinoma-in-situ-cis-detection-in-radical-cystectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-common-medications-that-influence-immunotherapy-response-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determining-individual-preferences-for-gynecomastia-avoidance-among-men-with-prostate-cancer-a-qual 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-treatment-with-disitamab-vedotin-plus-perioperative-toripalimab-in-patients-with-her2-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peripheral-blood-correlates-of-outcomes-with-adjuvant-tremelimumab-plus-durvalumab-for-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-correlates-of-brain-metastases-in-small-cell-carcinoma-of-the-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protact-a-first-in-human-phase-1-study-evaluating-the-safety-tolerability-and-anti-tumor-activit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-hit-ipik3cai-mutations-in-clinically-advanced-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-recurrent-non-muscle-invasive-bladder-cancer-with-ugn-301-zalifrelimab-alone-and-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-combinations-in-sarcomatoid-metastatic-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-serum-ldh-on-clinical-outcomes-in-patients-with-good-risk-metastatic-non-seminomatous-germ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interaction-between-obesity-and-vitamin-d-and-testosterone-and-vitamin-d-in-prostate-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-ctdna-status-with-upstaging-pathologic-outcomes-and-genomic-alterations-in-high-ris 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-in-patients-with-hiv-a-multisite-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cystectomy-free-survival-following-cretostimogene-grenadenorepvec-in-high-risk-bcg-unresponsive-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-metastatic-urothelial-cancer-in-a-multicenter-argentine-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-censorship-in-the-interpretation-of-outcomes-of-the-enfortumab-vedotin-plus-pembrolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-capability-of-combining-exodx-epi-and-pre-biopsy-prostate-mri-in-detecting-clinically-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-dose-escalationexpansion-study-of-regn10597-anti-pd-1-il2ra-il2-in-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-bone-metastases-in-men-with-low-psa-biochemical-recurrence-of-prostate-cancer-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/egfr-her2-alterations-in-advanced-urothelial-carcinoma-auc-a-retrospective-analysis-on-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-cardiovascular-disease-risk-factors-in-patients-with-prostate-cancer-initiating-novel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microplastics-and-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ascending-dose-escalation-of-belzutifan-plus-palbociclib-for-previously-treated-advanced-clear-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-enfortumab-vedotin-plus-pembrolizumab-versus-neoadjuvant-pembrolizumab-in-cisplatin-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-therapy-after-ipilimumab-and-nivolumab-in-advanced-renal-cell-carcinoma-a-multicenter-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/description-and-management-strategies-of-prespecified-treatment-emergent-adverse-events-teaes-amon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-disitamab-vedotin-plus-immunotherapy-in-locally-advanced-or-metastatic-ur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-trial-of-urinary-tumor-dna-utdna-testing-guided-cystoscopy-in-high-riskvery-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-evaluating-the-efficacy-and-safety-of-perioperative-enfortumab-vedotin-plus-toripal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-clinical-impact-of-actionable-genomic-alterations-in-non-clear-cell-renal-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blood-and-urine-liquid-biopsy-for-molecular-monitoring-in-her2-positive-muscle-invasive-bladder-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-multi-layered-omics-analysis-of-the-ubc-landscape-for-precision-medicine-and-its-clini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-and-predicting-non-cancer-mortality-risk-in-mhspc-following-doublet-therapy-in-the-stamp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-prostate-specific-antigen-psa-response-in-metastatic-castration-sensitive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-safety-and-efficacy-of-daily-oral-iangelica-gigasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-study-of-sup68sup-ga-psma-11-pet-combined-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chromophobe-renal-cell-carcinoma-long-term-survival-and-treatment-patterns-from-a-real-world-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-metastatic-urothelial-carcinoma-patients-discontinuing-enfortumab-vedotin-due-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-analysis-of-neoadjuvant-atezolizumab-in-upper-tract-urothelial-carcinoma-results-from-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-utility-of-neutrophillymphocyte-ratio-nlr-in-patients-receiving-177lu-psma-617-lupsma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/v-set-immunoregulatory-receptor-as-a-novel-molecular-target-for-genitourinary-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-patient-reported-outcomes-as-nonmuscle-invasive-bladder-cancer-clinical-trial-endp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-and-clinical-utility-of-a-six-gene-signature-for-aggressive-prostate-cancer-among-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patient-characteristics-and-treatment-patterns-among-patients-with-metastatic-castration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-transforming-total-neoadjuvant-therapy-neoteric-signals-a-step-forward-in-the-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-toxicity-with-androgen-receptor-pathway-inhibitors-in-metastatic-prostate-cancer-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-analysis-of-the-prognostic-significance-of-intraductal-carcinoma-of-the-prostate-idc-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/severe-acute-kidney-injury-after-abiraterone-vs-enzalutamide-in-advanced-prostate-cancer-a-seer-med 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radium-223-without-androgen-deprivation-therapy-adt-in-patients-pts-with-biochemically-recurrent-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-expression-and-genomic-alterations-in-plasmacytoid-urothelial-carcinoma-results-from-a-large-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-biochemical-and-clinical-predictors-of-castration-resistance-and-survival-in-metastatic-hor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-androgen-receptor-pathway-inhibitor-arpi-dose-reduction-on-overall-survival-of-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-study-of-gsk5458514-administered-alone-or-in-combination-with-other-anticancer-agents-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-enzalutamide-and-bipolar-androgen-therapy-on-clonal-hematopoiesis-and-clinical-outcomes-am 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epigenomic-alterations-associated-with-androgen-receptor-pathway-inhibitor-response-in-metastatic-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-combined-with-radiotherapy-versus-systemic-therapy-alone-for-oligometastatic-kidney 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-italic-rcc-study-a-randomized-study-of-clinical-and-humoral-impact-of-primary-tumor-ablation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/internet-based-lifestyle-intervention-to-eradicate-obese-frailty-in-prostate-cancer-survivors-the-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-vorolanib-combined-with-cadonilimab-in-previously-untreated-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trim28-mediated-sumoylation-of-erg-at-k389-and-its-association-with-cell-proliferation-parp-inhibit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-to-assess-peptidomimetic-carbonic-anhydrase-ix-imaging-and-therapy-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/direct-comparative-and-network-meta-analysis-of-parp-inhibitor-and-androgen-receptor-targeted-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarcomatoid-versus-rhabdoid-dedifferentiation-and-histologic-grade-specific-outcomes-in-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-deficiency-signature-hrdsig-status-in-ibrca12i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-large-language-model-framework-for-automated-extraction-of-pathology-data-in-radical-cystect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-and-longitudinal-body-composition-profile-association-with-immune-checkpoint-inhibitor-ici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-docetaxel-triplet-therapy-with-androgen-receptor-pathway-inhibitor-arpi-doublet-in-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-for-stage-iv-non-small-cell-lung-cancer-with-driver-alterations-asco-living-guideline-2026-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-pilot-trial-of-pre-visit-patient-education-as-preparation-for-decision-making-in-newly-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/save-a-multicenter-randomized-phase-2-trial-of-salvage-radiotherapy-srt-with-androgen-deprivation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-determinants-of-testosterone-recovery-following-androgen-deprivation-therapy-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serial-proteomic-characterization-of-plasma-extracellular-vesicles-ev-to-identify-changes-that-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-of-venous-tumor-thrombi-in-renal-cell-carcinoma-to-immune-checkpoint-inhibitor-therapy-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emotional-concerns-due-to-kidney-cancer-kc-and-disparities-in-patient-support-across-north-america 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-avelumab-axitinib-vs-sunitinib-in-patients-pts-with-very-favorable-risk-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-treatment-patterns-in-patients-pts-with-metastatic-castration-resistant-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-psma-pet-metrics-and-circulating-tumor-cell-rna-sequencing-to-predict-lupsma-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-cardiovascular-disease-and-adt-on-survival-disparities-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spectra-study-a-phase-ii-trial-of-supraphysiological-androgen-to-enhance-treatment-activity-with-dn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-with-immune-checkpoint-inhibitor-andor-enfortumab-vedotin-in-patients-with-mtap-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-piflufolastat-f18-imaging-on-disease-management-for-prostate-cancer-patients-observations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-kidney-injury-to-predict-cardiovascular-outcomes-following-radical-cystectomy-a-multicenter-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-plasma-metabolomic-profiling-of-metastatic-urothelial-carcinoma-muc-pre-and-post-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-impact-of-tgf-ss-activity-on-fibroblast-infiltration-and-immune-exclusion-in-mibc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-setd2-mutation-with-prognostic-features-and-susceptibility-to-acute-kidney-injury-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-sex-based-disparities-in-advanced-renal-cell-carcinoma-insights-from-the-real-world-meet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-surveillance-in-non-clear-cell-renal-cancer-is-current-practice-best-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-non-luminal-molecular-subtypes-and-complete-response-rates-after-neoadjuvant-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-her2-expression-and-ierbb2i-alterations-on-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-bleomycin-dose-omissions-on-clinical-outcomes-in-non-seminomatous-germ-cell-tumors-a-syst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-performance-of-immune-combinations-ici-ici-vs-ici-tki-in-metastatic-renal-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-gleason-pattern-4-length-on-adverse-surgical-pathology-and-oncologic-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-nephrectomy-in-patients-with-pathologic-complete-response-to-immune-checkpoint-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-enfortumab-vedotin-plus-pembrolizumab-versus-gemcitabine-plat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obrixtamig-bi-764532-in-patients-pts-with-relapsedrefractory-delta-like-ligand-3-dll3-high-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adc-target-signatures-in-urothelial-carcinoma-a-transcriptomic-framework-for-precision-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-mutations-tp53mut-as-a-predictive-biomarker-for-lutetium-177-psma-lu-psma-vs-docetaxel-ben 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-outcomes-of-nephrectomy-with-ivc-thrombectomy-analysis-from-a-large-multi-institutiona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-attrition-and-survival-outcomes-in-patients-with-metastatic-unclassified-renal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adiposity-and-response-to-adt-ar-pathway-inhibitors-arpi-in-men-with-metastatic-hormone-sensitiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/br31-trial-adjuvant-durvalumab-as-the-third-contender-in-resected-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-advanced-stage-prostate-cancer-over-the-last-decade-analysis-from-the-national-cancer-dat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-mrt-2359-a-highly-selective-oral-gspt1-molecular-glue-degrader-mgd-in-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-safety-analysis-of-a-randomized-phase-ii-trial-comparing-pembrolizumab-with-radiation-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-microsatellite-instabilitymismatch-repair-deficiency-phenotype-in-upper-tract-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-senescence-and-antigen-presentation-defects-in-bcg-unresponsive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-cabozantinib-and-nivolumab-in-metastatic-castration-resistant-prostate-cancer-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/features-of-early-and-late-recurrence-versus-de-novo-metastatic-ccrcc-findings-from-javelin-renal-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-hour-of-immune-checkpoint-inhibitors-icis-administration-in-metastatic-renal-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-long-term-outcomes-of-extreme-responders-to-first-line-treatment-of-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pragmatic-phase-2-trial-of-locally-ablative-therapy-in-oligo-progressive-genitourinary-gu-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastasis-directed-therapy-with-or-without-pembrolizumab-for-oligometastatic-clear-cell-renal-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-imutyhi-mutations-with-clinical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/county-level-educational-attainment-and-long-term-outcomes-in-older-men-with-prostate-cancer-a-seer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advanced-2-interim-efficacy-and-safety-data-in-bcg-unresponsive-participants-with-high-grade-non-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-microbiome-gmb-biomarkers-in-patients-pts-with-metastatic-castration-resistant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tobacco-use-and-survival-among-veterans-with-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravesical-t3011-an-il-12anti-pd-1-armed-oncolytic-hsv-1-in-bcg-naive-high-risk-nmibc-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-kidney-injury-marker-1-kim-1-in-metastatic-renal-cell-carcinoma-with-divergent-histolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bladder-cancer-innervation-does-it-affect-prognosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-analyses-of-bilateral-testicular-germ-cell-cancers-bitcoin-study-from-the-italian-germ-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redefining-multimodal-treatment-in-high-volume-metastatic-hormone-sensitive-prostate-cancer-prospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-study-to-evaluate-the-safety-and-efficacy-of-igermetostat-xnw5004-in-combination-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rc48g001-a-phase-2-study-of-disitamab-vedotin-in-her2-expressing-previously-treated-advanced-uc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-impact-of-her-2-expression-in-metastatic-urothelial-carcinoma-results-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/core-008-cohort-b-evaluating-intravesical-cretostimogene-grenadenorepvec-in-patients-with-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-pain-and-symptomatic-skeletal-events-in-the-phase-3-psmaddition-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-darolutamide-and-adt-in-patient-subgroups-by-baseline-comorbidities-and-conco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-multicenter-open-label-study-evaluating-the-efficacy-and-safety-of-dabogratinib-tyra-300 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-lutetium-177-psma-617-in-metastatic-castration-resistant-prostate-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-circulating-tumor-dna-in-patients-with-renal-cell-carcinoma-at-increased-risk-of-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-early-termination-in-phase-2-3-genitourinary-oncology-trials-a-two-decade-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-relative-dose-intensity-to-predict-survival-outcomes-in-patients-treated-with-enfortumab-vedot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omaha-004-phase-3-trial-of-cyp11a1-inhibitor-opevesostat-versus-androgen-receptor-pathway-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-survival-outcomes-in-veterans-receiving-radium-223-for-metastatic-castr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-role-of-peripheral-blood-erythroblasts-for-treatment-intensification-in-metastatic-hormon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-effectiveness-of-novel-doublet-therapies-for-metastatic-hormone-sensitive-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-expansion-study-of-sup212sup-pb-advc001-in-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-clinical-trial-of-autologous-gamma-delta-t-cells-genetically-engineered-with-a-chimeric-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-radiosensitivity-biomarker-for-radiation-induced-gu-toxicity-following-radiation-therapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-ifgfr3i-genomicalterations-in-liquid-biopsies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imtapi-loss-in-sarcomatoid-renal-cell-carcinoma-srcrcc-a-genomic-landsca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-neoadjuvant-therapy-utilization-and-outcomes-in-patients-with-muscle-invasive-bladder-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-docetaxel-bladder-penetration-following-gemcitabine-pretreatment-an-analysis-of-concentr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-angiogenic-myeloid-cytokine-axis-to-predict-benefit-from-first-line-immune-checkpoint-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insulin-pathway-changes-in-localized-prostate-cancer-a-multi-institutional-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-dynamics-in-bone-dominant-metastatic-castration-resistant-prostate-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-mutational-burden-on-clinical-outcomes-in-muscle-invasive-bladder-cancer-patients-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-phase-1-dose-escalation-results-of-vir-5500-amx-500-a-dual-masked-pro-xten-t-cell-eng 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-progression-and-toxicity-in-high-risk-clear-cell-renal-cell-carcinoma-patients-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-nccn-based-risk-groups-to-the-proteus-definition-of-high-risk-localized-prostate-cancer-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tropion-urothelial03-a-phase-23-study-of-datopotamab-deruxtecan-dato-dxd-platinum-chemotherapy-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-trial-of-neoadjuvant-leuprorelin-darolutamide-or-both-prior-to-radical-prostatectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-results-from-the-phase-1-study-of-gotistobart-bnt316onc-392-in-combination-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-zanzalintinib-with-oral-etoposide-following-high-dose-chemotherapy-in-patients-with-rela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-putative-liquid-biopsy-gene-panel-for-predicting-liver-metastasis-in-castration-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-chemoradiotherapy-regimens-in-muscle-invasive-bladder-cancer-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-the-molecular-assessment-of-mri-targeted-prostate-biopsies-utilizing-near-real-time-stimul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-between-clinical-genomic-and-ai-based-risk-stratification-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bone-fractures-with-androgen-pathway-inhibitors-arpi-in-patients-pts-with-prostate-cancer-pca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-prostate-specific-antigen-kinetics-between-androgen-receptor-signaling-inhibitor-doubl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tulmistar-01-a-phase-iii-dose-optimization-study-of-tulmimetostat-in-combination-with-luxdegalutam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-circulating-tumor-dna-as-a-biomarker-in-testicular-seminoma-and-non-seminomatous-germ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-in-circulating-tumor-dna-from-a-multicenter-prospective-study-of-radium-223-in-bon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-age-number-of-cycles-of-chemotherapy-and-presence-of-visceral-metastases-on-psa-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ideate-prostate02-a-phase-12-open-label-umbrella-substudy-of-ifinatamab-deruxtecan-based-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-eight-first-line-regimens-in-metastatic-hormone-sensitive-prostate-cancer-mhs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-cost-impact-of-cabazitaxel-versus-lutetium-177-vipivotide-tetraxetan-lu-psma-for-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-improvement-initiative-to-increase-osteoporosis-screening-in-patients-with-prostate-cancer-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-abiraterone-vs-enzalutamide-in-metastatic-castration-sensitive-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-biomarker-characteristics-of-treatment-emergent-neuroendocrine-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-neoadjuvant-chemotherapy-relative-dose-intensity-on-pathological-complete-response-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-combined-chemotherapy-and-immunotherapy-for-upper-tract-urothelial-carcinoma-final-resu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-adjuvant-hyperthermic-intraperitoneal-chemotherapy-in-patients-with-locally-advanced-colon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nci9673-part-b-etctn-randomized-phase-ii-study-of-nivolumab-with-or-without-ipilimumab-in-refract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bruin-313-and-314-trials-open-the-door-for-noncovalent-bruton-tyrosine-kinase-inhibition-as-initial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-year-follow-up-of-nivolumab-avd-versus-brentuximab-vedotin-avd-in-adolescents-with-advanced-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pirtobrutinib-versus-ibrutinib-in-treatment-naive-and-relapsedrefractory-chronic-lymphocytic-leukem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/north-star 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extended-endocrine-therapy-following-5-years-of-adjuvant-luteinizing-hormone-releasing-hormone-agoni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/methodologic-and-reporting-gaps-in-the-surf-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-revisiting-methodologic-paradigms-in-local-therapies-for-hepatocellular-carcinoma-insigh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-pirtobrutinib-for-treatment-naive-chronic-lymphatic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-in-patients-with-metastatic-castration-resistant-prostate-cancer-asco-living-guide-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatic-arterial-infusion-pump-chemotherapy-in-patients-with-unresectable-intrahepatic-cholangiocarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-considerations-in-early-stage-estrogen-receptor-positive-ibrca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bruin-cll-313-randomized-phase-iii-trial-of-pirtobrutinib-versus-bendamustine-plus-rituximab-in-unt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revisiting-methodologic-paradigms-in-local-therapies-for-hepatocellular-carcinoma-insights-from-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/all-things-excellent-are-as-difficult-as-they-are-rare 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-computational-histology-artificial-intelligence-powered-predictive-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-benefit-of-chemoradiotherapy-versus-chemotherapy-after-induction-therapy-for-conversion-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-simultaneous-durvalumab-and-platinum-based-chemoradiotherapy-in-unresectable-stage-iii-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/upfront-modified-folfoxiri-plus-panitumumab-for-irasbrafi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-benefit-of-specialist-palliative-care-in-oncology-rethinking-clinical-trial-design 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-major-pathologic-response-the-best-surrogate-end-point-for-neoadjuvant-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-neoadaura-can-we-afford-to-overlook-objective-response-rates-and-is-major-pathologic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/music-therapy-versus-cognitive-behavioral-therapy-via-telehealth-for-anxiety-in-survivors-of-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sustained-benefit-of-blinatumomab-in-infants-with-ikmt2ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mothers-grief 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phased-variant-supported-circulating-tumor-dna-as-a-prognostic-biomarker-after-first-line-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-validation-of-circulating-tumor-dna-measurable-residual-disease-after-first-line-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-lymph-node-and-extranodal-extension-assessment-improves-risk-stratification-in-oropharynge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-efficacy-in-mismatch-repair-proficient-colorectal-cancer-patients-with-and-without-liv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-successful-outcomes-of-newly-diagnosed-t-lymphoblastic-lymphoma-results-from-childrens-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadaura-can-we-afford-to-overlook-objective-response-rates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-key-considerations-for-the-lenvatinib-pembrolizumab-chemotherapy-regimen-in-advanced-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-atezolizumab-in-early-stage-non-small-cell-lung-cancer-signals-silences-and-the-need-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/twelve-month-results-from-the-cisto-study-comparing-radical-cystectomy-versus-bladder-sparing-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/key-considerations-for-the-lenvatinib-pembrolizumab-chemotherapy-regimen-in-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-noninferiority-trial-of-a-liberalized-diet-versus-the-neutropenic-diet-in-hematopoietic-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomically-smoldering-multiple-myeloma-is-not-a-distinct-entity-but-a-collection-of-monoclonal-gamm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-validated-staging-system-for-light-chain-al-amyloidosis-with-stage-iiic-defining-ultra-poor-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-chance-to-heal-with-cold-hard-steel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ifinatamab-deruxtecan-in-patients-with-extensive-stage-small-cell-lung-cancer-primary-analysis-of-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benefits-harms-and-burden-of-colorectal-cancer-screening-among-childhood-cancer-survivors-previous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-improving-the-reporting-of-long-term-effects-in-the-impower010-trial-and-adjuvant-atezo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/b7-h3-as-a-universal-target-for-solid-tumor-therapy-clinical-promise-and-biological-complexity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-the-reporting-of-long-term-effects-in-the-impower010-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-epirubicin-plus-cyclophosphamide-followed-by-taxanes-with-or-without-carboplatin-in-early-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-cancer-during-pregnancy-asco-guideline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-optimizing-control-arms-in-chronic-lymphocytic-leukemia-clinical-trials-the-bruin-cll-321 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumultuous-development-of-venetoclax-in-t1114-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/smell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/noncomparative-comparisons-the-paradox-of-randomized-noncomparative-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-refining-myeloma-precursors-and-their-risk-of-progression-through-genomics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-ribociclib-plus-letrozole-in-women-with-recurrent-low-grade-serous-carcinoma-of-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomics-define-malignant-transformation-in-myeloma-precursor-conditions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-control-arms-in-chronic-lymphocytic-leukemia-clinical-trials-the-bruin-cll-321-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venetoclax-dexamethasone-versus-pomalidomide-dexamethasone-in-t1114-positive-relapsedrefractory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dinutuximab-beta-added-to-temozolomide-based-chemotherapy-for-children-with-relapsed-and-refractory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-noncomparative-comparisons-the-paradox-of-randomized-noncomparative-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-characterization-of-response-to-tyrosine-kinase-inhibitor-plus-immunotherapy-in-msspmmr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-toxicity-outcomes-of-total-neoadjuvant-flot-versus-perioperative-flot-in-resectable-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mode-of-presentation-and-symptoms-of-colorectal-cancer-crc-by-primary-tumor-and-molecular-subgroup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/repertoire-real-world-treatment-tx-patterns-and-outcomes-in-us-patients-pts-with-her2-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-and-sintilimab-plus-transcatheter-arterial-chemoembolization-for-unresectable-hepatocellul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-cell-intrinsic-c5ar1-in-colorectal-cancer-survival-and-chemoresistance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-art-123-in-combination-with-folfox-bevacizumab-for-patients-with-metastatic-color 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-claudin182-expression-in-gastric-cancer-a-large-single-center-cohort-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-low-dose-regorafenib-with-pembrolizumab-for-patients-with-msi-h-colorectal-cancer-regpem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-about-the-impact-of-tumor-regression-grade-on-pancreatic-adenocarcinoma-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-brca2-braf-apc-and-pten-expression-on-the-prognostic-significance-of-surgical-margin-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-patterns-and-outcomes-among-early-onset-versus-average-onset-gastroenteropancreatic-neuro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-novel-polymeric-fdump-cf10-versus-5-fu-in-efficacy-and-tolerability-in-preclinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-metastatic-sites-and-lauren-subtype-on-survival-outcomes-of-first-line-pd-1-inhibitors-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-data-of-oxaliplatin-retreatment-in-patients-with-metastatic-colorectal-cancer-in-a-real-wor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-chimeric-antigen-receptor-t-cell-therapy-in-diffuse-large-b-cell-lymphoma-long-te 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-rare-histologic-variants-of-esophageal-cancer-a-national-cancer-database-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-analysis-of-her2-status-based-on-central-and-local-testing-results-from-the-destiny-gast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cracking-the-code-clinical-predictors-of-brain-metastases-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-biliary-drainage-strategy-and-in-hospital-outcomes-in-malignant-biliary-obstruction-a-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intra-arterial-gemcitabine-versus-intravenous-gemcitabine-pharmacokinetic-and-pharmacodynamic-sub-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-docetaxel-oxaliplatin-and-s-1-therapy-for-patients-with-large-type-3-or-type-4-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acupuncture-and-acupressure-to-mitigate-chemotherapy-induced-peripheral-neuropathy-for-gi-cancer-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lanreotide-octreotide-switch-in-advanced-gastrointestinal-neuroendocrine-tumors-ginets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-multicenter-retrospective-analysis-of-systemic-treatments-in-well-differentiated-grade-3-g3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-caused-by-gall-bladder-carcinoma-in-the-united-states-population-from-1999-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-atezolizumab-plus-bevacizumab-in-patients-with-unresectable-hepatocellular-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-rc48-in-combination-with-sintilimab-and-xelox-for-periope 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myeloid-stromal-il1rap-as-a-therapeutic-vulnerability-in-pancreatic-cancer-rationale-for-a-neoadjuv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-treatment-strategy-for-locally-advanced-pancreatic-cancer-using-carbon-ion-radiothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-adjuvant-chemotherapy-benefit-in-younger-and-older-molecular-residual-disease-positive-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-of-immunotherapy-versus-standard-of-care-in-microsatellite-stable-metastatic-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-routine-collection-of-electronic-patient-reported-outcome-measures-eproms-coupled-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peptide-receptor-radionuclide-therapy-lu-177-prrt-in-neuroendocrine-tumors-net-over-16-years-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gata6-expression-with-ca19-9-levels-as-biomarkers-in-resectable-pancreatic-adenocarcinoma-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-trial-of-medical-cannabis-to-reduce-symptom-burden-in-patients-with-newly-diag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inappropriate-use-of-tumor-markers-for-gi-cancer-screening-in-asymptomatic-patients-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-clinical-outcomes-of-metastatic-gastric-cancer-real-world-evidence-from-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-revumenib-in-patients-pts-with-advanced-colorectal-cancer-crc-and-other-sol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keystep-008-pembrolizumab-pembro-based-combinations-for-microsatellite-instability-high-msi-hm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-treatment-trends-in-brca-mutated-metastatic-pancreatic-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/continuous-maintenance-or-intermittent-first-line-1l-therapy-for-advanced-pancreatic-cancer-apc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonists-and-pancreatic-cancer-risk-a-meta-analysis-of-real-world-and-trial-evidence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subgroup-analyses-from-the-phase-3-panova-3-trial-of-tumor-treating-fields-ttfields-with-gemcitabi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-pancreatic-versus-duodenal-adenocarcinoma-a-national-cancer-database-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-cbx-12-for-metastatic-chemotherapy-refractory-microsatellite-stable-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-assisted-automated-abstraction-for-enhanced-patient-insights-in-gastrointestinal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-barriers-to-cancer-care-in-a-war-zone-a-study-of-challenges-facing-patients-with-gi-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amigo-a-phase-2-trial-of-amivantamab-in-iegfri-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-prognostic-impact-of-idh-mutations-in-intrahepatic-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-immune-landscape-of-early-onset-versus-average-onset-well-differentiated-enteropancrea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficacy-and-safety-of-immunotherapy-combinations-as-first-line-treatment-for-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immune-checkpoint-inhibitors-in-colorectal-cancer-a-network-meta-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-and-responses-to-her2-directed-treatment-in-gastrointestinal-cancers-based-on-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiotherapy-scrt-followed-by-immunochemotherapy-plus-fruquintinib-as-the-total-neoad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-adverse-events-iraes-in-lynch-vs-non-lynch-microsatellite-instability-high-msi-hig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-lbl-007-anti-lag-3-plus-tislelizumab-anti-pd-1-and-chemotherapy-as-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-hoc-central-radiological-review-of-the-altair-study-in-patients-with-molecular-residual-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-trial-of-medical-cannabis-to-reduce-symptom-burden-in-patients-with-newly-diag-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intratumoral-immune-landscape-changes-after-neoadjuvant-chemoradiation-in-esophageal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bxq-350-efficacy-and-safety-evaluation-in-first-line-mcrc-patients-a-phase-1b2-study-of-bxq-350-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-practice-patterns-of-radiotherapy-utilization-in-pancreatic-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/no-operation-after-short-course-radiotherapy-followed-by-consolidation-chemotherapy-in-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-of-epithelial-neoplasms-of-the-appendix-insights-across-histological-subtypes-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bold-100-001-a-randomized-phase-2-study-of-bold-100-plus-folfox-vs-folfox-in-patients-with-refracto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-new-standard-for-coeliac-plexus-radiotherapy-contouring 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-circulating-exosomal-microrna-signature-for-the-detection-of-minimal-residual-disease-after-curati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/foxtrot-predictive-effects-of-ierbb2i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-liver-cancer-stage-from-medicare-claims-data-a-machine-learning-approach-to-broaden-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-study-on-the-efficacy-and-safety-of-bxq-350-a-first-in-class-sphingolipid-metabolism-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimal-residual-disease-mrd-trials-in-colorectal-cancer-crc-an-overview-of-a-heterogeneous-fie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-regulation-of-cldn182-expression-during-immunotherapy-implications-for-biomarker-driven-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consensus-molecular-subtypes-and-divergent-genomic-landscapes-with-clinical-implications-in-biliary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-uncommon-idpydi-polymorphisms-with-sever 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-perioperative-tumor-treating-fields-novottf-200tp-combined-with-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-trends-and-misclassification-patterns-of-hepatocholangiocarcinoma-a-seer-database-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-head-to-head-comparison-of-gpt-based-prognostic-predictions-and-oncologists-in-gastrointestinal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-update-on-the-impact-of-covid-19-on-colorectal-cancer-screening-using-medicare-claims-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-timely-diagnosis-of-early-onset-colorectal-cancer-a-systematic-review-and-qualitative-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-to-reveal-colorectal-cancer-molecular-subtype-information-from-ctdna-epigenetics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-collaboration-between-surgeons-and-medical-oncologists-affects-outcomes-for-patients-with-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-primary-malignancy-spm-in-localized-gastrointestinal-gi-cancer-a-national-database-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-microwave-ablation-versus-open-surgical-resection-in-colorectal-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tolerability-and-outcomes-after-neoadjuvant-and-definitive-radiation-of-elderly-patients-with-locali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anastomotic-leak-and-oncologic-outcomes-after-colorectal-cancer-resection-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cruk-phase-ii-trial-of-ginisortamab-with-1-1st-line-gemcitabine-nab-paclitaxel-ag-or-2-mek 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-in-combination-with-chemotherapy-as-conversion-therapy-for-esophageal-squamous-cell-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-brachytherapy-use-and-survival-outcomes-in-rectal-adenocarcinoma-insights-from-the-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-analysis-of-activity-in-esophageal-cancer-during-phase-1-dose-escalation-of-iks014-a-her2-tar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/river-mpdac-a-phase-2b3-study-of-ponsegromab-for-the-treatment-of-cachexia-in-patients-with-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanidatamab-chemotherapy-ct-tislelizumab-for-first-line-1l-her2-positive-her2-locally-adv-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-performance-of-an-improved-colorectal-cancer-crc-screening-blood-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-botensilimab-and-agen1423-an-anti-cd73-tgfv-trap-bifunctional-antibody-in-subje 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-advanced-hepatocellular-carcinoma-ahcc-patients-treated-with-atezolizumab-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-safety-outcomes-of-first-line-immune-checkpoint-inhibitor-combinations-versus-tyrosine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-nutritional-index-as-a-predictor-of-survival-in-metastatic-gastroesophageal-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-among-metastatic-colorectal-cancer-mcrc-patients-with-liver-metastase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-systemic-therapy-in-patients-with-hepatocellular-carcinoma-and-decompensated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-for-incurable-anal-cancer-according-to-hiv-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-framework-for-contextual-mass-categorization-leveraging-explainable-ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-plus-chemotherapy-versus-pd-1-inhibitor-plus-chemotherapy-as-first-line-1l-treatment-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-total-neoadjuvant-therapy-tnt-on-overall-complete-response-cr-for-locally-advanced-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-hepatic-artery-infusion-chemotherapy-haic-or-lenvatinib-combined-with-sinti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discovery-of-a-functional-biomarker-for-sensitivity-to-poly-adp-ribose-polymerase-inhibitors-parpi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-relapse-and-lack-of-benefit-from-adjuvant-chemotherapy-following-surgical-resection-of-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-randomized-double-blind-placebo-controlled-study-to-evaluate-ly3537021-for-the-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-for-colorectal-cancer-with-synchronous-and-exclusive-peritoneal-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reproducibility-and-clinical-concordance-of-a-tumor-informed-mrd-assay-in-patients-with-resected-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-the-randomized-phase-2-study-1801-part-3b-of-elraglusib-plus-gemcitabinenab-paclitax 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-a-false-positive-stool-multi-target-dna-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-dogma-association-between-radiation-dose-and-pathologic-outcomes-or-survival-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/onc201-for-chemoprevention-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-mao-b-a-novel-gut-brain-axis-link-in-colorectal-cancer-progression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarcopenia-measured-radiographically-as-a-prognostic-and-predictive-factor-of-response-to-perioperat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-enfortumab-vedotin-in-patients-with-advanced-or-metastatic-colorectal-cancer-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociocultural-and-educational-determinants-of-delayed-diagnosis-in-anal-cancer-insights-from-a-5-ye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-of-tissue-free-ctdna-monitoring-in-patients-with-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/innovative-carbon-ion-radiotherapy-for-unresectable-pancreatic-cancer-using-sib-and-let-optimization 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zolbetuximab-pembrolizumab-and-chemotherapy-as-first-line-treatment-for-patients-with-cldn182-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-between-nivolumab-plus-ipilimumab-folfox-and-nivolumab-plus-folfox-therapy-as-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-ii-trial-of-perioperative-chemotherapy-plus-atezolizumab-and-tiragolumab-in-localized-esopha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-as-a-modifiable-risk-factor-in-familial-adenomatous-polyposis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/too-late-to-help-disparities-in-palliative-and-hospice-care-among-veterans-with-pancreatic-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-epidermal-growth-factor-receptor-inhibitors-in-locally-advanced-and-metastatic-anal-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-study-of-arfolitixorin-in-combination-with-5-fluorouracil-5fu-oxaliplatin-and-bevaciz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-c-met-expression-in-patients-with-advanced-gastroesophageal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-in-advanced-radiation-technique-use-and-survival-for-pancreatic-ductal-adenocarcinoma-and-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-tumor-intrinsic-pathways-to-identify-novel-targets-in-immune-cold-esophagogastric-adenocarcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-long-term-survival-from-metastatic-colorectal-cancer-a-single-centre-irish-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ibii-study-of-asp-1929-photoimmunotherapy-pit-for-esophageal-cancer-ineligible-for-curative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-of-patients-diagnosed-with-metastatic-pancreatic-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-in-hospital-mortality-among-pancreatic-cancer-patients-using-modified-cancer-frailty-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-phase-2-study-of-a-novel-dll4-vegf-a-bispecific-antibody-tovecimig-ctx-009-as-a-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-gemcitabine-plus-cisplatin-with-immune-checkpoint-inhibitor-and-with-s-1-in-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreatic-acinar-cell-carcinoma-pacc-a-comparative-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-personalized-evidence-based-care-for-veterans-with-hepatocellular-carcinoma-hcc-insigh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-phase-1b2-trial-of-gemcitabine-cisplatin-nab-paclitaxel-and-tislelizumab-gentis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-factors-related-to-survival-in-advanced-pancreatic-cancer-in-elderly-patients-at 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-irasbrafi-mutations-and-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-localized-pancreatic-cancer-treated-with-neoadjuvant-chemotherapy-nac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibii-dose-escalation-and-dose-expansion-study-of-valemetostat-tosylate-ds-3201b-with-ate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuroendocrine-carcinoma-of-the-esophagus-a-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-hepatic-arterial-infusion-pump-haip-therapy-on-disease-control-and-survival-outcome-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-randomized-multicenter-phase-3-study-of-trastuzumab-deruxtecan-t-dxd-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-management-of-perioperative-flot-for-resectable-gastric-gastroesophageal-junction-or-esop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-arv-806-a-protac-kras-g12d-degrader-in-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-rock2-signaling-on-resistance-to-kras-inhibitors-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ponsegromab-in-patients-with-colorectal-cancer-and-cachexia-a-subgroup-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-time-toxicity-of-metastatic-pancreatic-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-the-oncolytic-virus-svv-001-in-combination-with-nivolumab-and-ipilimumab-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5hmc-as-a-novel-liquid-biopsy-biomarker-for-colorectal-cancer-to-enable-detection-and-unveil-tumor-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/apixaban-versus-rivaroxaban-for-venous-thromboembolism-in-gastric-cancer-insights-from-a-propensity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-the-timing-of-recurrence-and-circulating-tumor-dna-ctdna-doubling-time-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-assisted-endoscopic-diagnosis-of-upper-gastrointestinal-neoplasia-a-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-gastric-cancer-mortality-by-subsite-cardia-vs-non-cardia-and-racial-disparities-from-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sox-tegafur-plus-oxaliplatin-plus-anti-pd-1-antibody-with-or-without-car-like-t-cell-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-performance-of-liquid-rna-l-rna-biopsy-in-a-gastrointestinal-cancer-segment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-disease-stabilization-and-toxicity-outcomes-of-immune-checkpoint-inhibitors-in-gastroente 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sorbitol-supplemented-diet-combined-with-neoadjuvant-chemoimmunotherapy-in-locally-advanced-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-role-of-pik3ca-and-co-alterations-in-advanced-biliary-tract-cancer-a-multicenter-retrosp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bxq-350-in-combination-with-folfox7-and-bevacizumab-evaluation-of-effect-on-oxaliplatin-induced-cip-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/helicobacter-pylori-and-risk-of-esophageal-cancer-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-gastrectomy-tg-versus-distal-gastrectomy-dg-for-distal-diffuse-gastric-cancer-gc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-demographic-reporting-in-clinical-trials-supporting-nccn-gastric-cancer-guidelines 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nutritional-status-cachexia-and-sarcopenia-as-predictors-of-mortality-in-colorectal-cancer-a-nati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profiling-tumor-characteristics-and-outcomes-in-colorectal-cancers-crc-from-carriers-of-the-recess 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-analysis-to-predict-the-clinical-benefit-of-everolimus-in-gastro-entero-pancreatic-neuroen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diffusion-weighted-magnetic-resonance-imaging-versus-surgical-staging-in-patients-with-colorectal-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-predictive-epigenetic-signatures-psig-for-risk-stratification-of-pancreatic-ductal-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-trastuzumab-deruxtecan-t-dxd-with-volrustomig-and-fluoropyrimidine-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breakwater-phase-3-post-hoc-subgroup-analyses-by-age-in-patients-pts-with-braf-v600e-mutant-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-fertility-preservation-services-among-commercially-insured-adults-with-early-onset-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/flipi24-a-modern-prognostic-model-and-clinical-trial-enrichment-tool-for-newly-diagnosed-follicular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-response-to-gemcitabine-based-neoadjuvant-therapy-on-the-outcomes-of-gemcitabine-plus-nab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-variations-in-gastrointestinal-cancer-mortality-a-comprehensive-analysis-of-us-regiona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-predictors-of-90-day-all-cause-readmission-in-hepatocellular-carcinoma-a-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-peripheral-angptl3-on-the-efficacy-of-anti-pd1-therapy-for-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-the-modified-glasgow-prognostic-score-in-patients-with-metastatic-pancreatic-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/curative-therapy-after-atezolizumab-and-bevacizumab-treatment-for-unresectable-hepatocellular-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stability-of-immune-microenvironment-changes-associated-with-progression-risk-in-barretts-esophagus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-cf33-hnis-oncolytic-virus-on-m2-macrophages-and-tumor-microenvironment-in-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-surgical-procedures-and-short-and-mid-term-outcomes-for-transverse-colon-cancer-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-potentially-actionable-genomic-alterations-in-early-onset-versus-later-onset 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-whole-genome-analysis-of-colorectal-cancer-conductor-study-integrating-rasbraf-ms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-two-year-survival-in-patients-receiving-chemotherapy-for-metastatic-pancreatic-ductal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-biomarker-analysis-and-clinical-outcomes-of-the-pd-1tgfvr2-bispecific-antibody-inca33890-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-hepatic-arterial-infusion-pump-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/small-cell-carcinoma-of-the-esophagus-a-seer-based-analysis-of-stage-stratified-radiotherapy-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-barriers-and-missed-opportunities-for-early-diagnosis-in-young-onset-biliary-tract-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-ecog-performance-status-ps-and-patient-reported-outcomes-pros-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-dose-escalation-versus-fixed-dosing-in-refractory-metastatic-colorectal-cancer-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-metastatic-dmmr-immunotherapy-commit-study-a-randomized-phase-iii-study-of-atez 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanzalintinib-versus-everolimus-in-patients-with-previously-treated-advanced-neuroendocrine-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-oxaliplatin-with-s-1-sox-versus-s-1-in-patients-with-stage-ii-iii-gastric-or-gastro-oesop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop-2-expression-and-the-tumor-microenvironment-in-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-vilanterol-in-combination-with-a-cldn182-bispecific-antibody-in-patients-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-metastatic-distribution-in-microsatellite-stable-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteogenomic-interrogation-of-gastrointestinal-neuroendocrine-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/skeletal-muscle-loss-during-neoadjuvant-chemotherapy-as-a-predictor-of-major-postoperative-complicat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pain-mitigation-in-pancreatic-adenocarcinoma-a-long-term-analysis-of-denervation-via-transvascular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmasking-the-lethality-national-mortality-patterns-of-pancreatic-cancer-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alliance-a022104nrg-gi010-a-randomized-phase-iiiii-trial-testing-the-efficacy-of-triplet-versus-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/majority-of-people-minority-of-places-the-people-place-gap-in-us-biliary-tract-cancer-trial-access 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathological-complete-response-after-systemic-conversion-therapy-and-curative-resection-in-initially 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibiotic-therapy-and-outcomes-with-gemcitabine-cisplatin-and-durvalumab-in-advanced-cholangiocarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-predictors-of-local-recurrence-after-crt-and-surgery-in-locally-advanced-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-nalirifox-nanoliposomal-irinotecan-oxaliplatin-with-fluorouracil-and-folinic-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-profiling-and-demographic-analysis-of-appalachian-and-non-appalachian-patients-with-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erbb2her2-status-in-biliary-tract-cancer-patients-in-the-spanish-retud-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-nanoliposomal-irinotecan-with-tas102-and-bevacizumab-for-patients-with-refractor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/descriptive-analysis-of-outcomes-in-participants-with-combined-hepatocellular-cholangiocarcinoma-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-11b-study-of-the-theranostic-pair-ryz811-diagnostic-and-ryz801-therapeutic-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-patients-pts-with-child-pugh-class-b-cp-b-liver-function-at-progression-aft 2026-08-24 monthly 0.7 https://rjrindex.com/articles/claudin-182-and-trop-2-as-emerging-biomarkers-in-biliary-tract-cancers-expression-analysis-and-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-analysis-results-of-a-phase-ii-trial-of-laparoscopicrobotic-total-gastrectomy-with-spleen-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ikf-035abc-hcc-a-phase-iiib-randomized-multicenter-open-label-trial-of-atezolizumab-plus-bevaci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-pd-1-antibody-toripalimab-combined-with-chemotherapy-versus-chemotherapy-alone-in-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-comparing-the-use-of-glp-1-agonists-in-patients-with-colon-cancer-and-comorbid-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pattern-of-progression-in-advanced-hepatocellular-carcinoma-treated-with-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immune-checkpoint-inhibitors-icis-for-localized-dmmrmsi-h-gastroesophageal-cancers-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neo-adjuvant-radiotherapy-prior-to-endoscopic-submucosal-dissection-for-superficial-esophageal-squam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-sociodemographic-trends-of-hepatocellular-carcinoma-in-nevada-a-decade-long-statew 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-genomic-characterization-of-itp53i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-trastuzumab-deruxtecan-versus-real-world-treatment-in-her2-amplified-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-early-onset-colorectal-cancer-in-the-united-states-an-epidemiologic-investigation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnical-disparities-in-treatment-outcomes-in-patients-with-advanced-hcc-who-received-fir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-cfdna-fragment-level-analysis-a-genome-scanning-approach-for-detection-of-color 2026-08-24 monthly 0.7 https://rjrindex.com/articles/italian-prospective-observational-realflot-study-four-year-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-first-line-anti-egfr-antibody-versus-anti-vegf-therapy-stratified-by-dna-methyl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mtap-loss-in-anal-melanoma-a-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-anlotinib-combined-with-penpulimab-and-nab-paclitaxel-as-first-line-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunohistochemical-genetic-and-transcriptomic-profiles-of-jejunoileal-adenocarcinoma-compared-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-of-systemic-therapies-for-advanced-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accru-gi-1810-trifluridinetipiracil-ftd-tpi-or-paclitaxel-pac-in-combination-with-ramucirumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-hepatocellular-carcinoma-hcc-incidence-and-impact-of-hepatitis-c-antiviral-therapy-a-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/levity-as-a-tool-for-difficult-conversations-healthcare-provider-experiences-with-the-butts-amp-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-and-potential-therapeutic-implications-of-molecular-testing-utilizing-a-large-da 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-cannabidiol-cbd-to-prevent-neuropathy-cipn-in-colorectal-cancer-crc-chemotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lap-net1-phase-1b-study-investigating-the-association-of-np137-with-mfolfirinox-in-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lean-individuals-with-metabolic-dysfunction-associated-steatotic-liver-disease-and-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-to-evaluate-the-safety-tolerability-and-preliminary-efficacy-of-a-heterologous-pri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-benmelstobart-ben-combined-with-concurrent-chemoradiotherapy-ccrt-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-as-a-decision-support-tool-for-practicing-oncologists-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-recurrence-in-a-diverse-population-based-sample-of-adults-with-early-onset-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-folfirinox-and-sbrt-for-borderlinelocally-advanced-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trifluridinetipiracil-and-pembrolizumab-combination-as-later-line-treatment-in-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intraperitoneal-therapies-ip-for-pancreatic-ductal-adenocarcinoma-pdac-a-systematic-synthesis-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-evaluation-of-immunotherapy-combination-approaches-versus-tyrosine-kinase-inhibitor-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-biomarker-testing-and-treatment-selection-by-oncologists-caring-for-patients-pts-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-smoking-on-immunotherapy-outcomes-in-gastric-gastro-esophageal-junction-and-esophageal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sarcopenia-on-short-and-long-term-outcomes-after-multimodal-therapy-for-esophageal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-urban-disparities-in-pancreatic-cancer-mortality-hotspots-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-and-prognostic-role-of-protease-activated-receptors-pars-in-colorectal-cancer-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-and-physician-preferences-for-third-line-or-later-3l-treatments-of-metastatic-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emergency-department-diagnosis-and-guideline-concordant-care-in-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-flot-in-gastric-cancer-effect-on-survival-among-east-asian-patients-in-a-canadian-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-and-income-related-disparities-in-survival-outcomes-in-patients-with-pancreatic-neuroendocrine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colonoscopy-choices-in-a-changing-world-do-gender-preferences-still-exist-for-colonoscopy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-efficacy-and-use-of-immunotherapy-in-treatment-of-microsatellite-instability-low 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-intraperitoneal-cf33-hnis-combined-with-pd-l1-blockade-on-gastric-cancer-peritoneal-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-sting-agonist-adu-s100-combined-with-a-cldn182-bispecific-antibody-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-open-label-single-arm-multi-center-study-of-trans-arterial-tirapazamine-embolization-ta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-and-30-day-readmissions-among-hepatocellular-carcinoma-patients-hospitalized-for-portal-ve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-presurgical-circulating-tumor-dna-ctdna-levels-and-other-clinical-factors-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-variation-and-regulation-of-mica-alters-natural-killer-cell-mediated-immunosurveillance-in-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-of-peritoneal-metastasis-pm-as-exclusion-criteria-in-clinical-trials-of-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-alter-pa-001-trial-a-multicenter-open-label-randomized-phase-ii-trial-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inflammatory-and-immune-marker-dynamics-following-intratumoral-alpha-dart-for-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-hepatocellular-carcinoma-using-red-blood-cell-dna-signatures 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytoreductive-surgery-crs-with-hyperthermic-intraperitoneal-chemotherapy-hipec-in-malignant-peri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indian-hedgehog-expression-and-association-with-cetuximab-benefit-in-metastatic-colorectal-cancer-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oxaliplatin-induced-portal-hypertension-in-colorectal-cancer-a-systematic-review-of-incidence-mech 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-randomized-controlled-trial-to-confirm-efficacy-of-surgery-plus-postoperative-dose-modifie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-disparities-in-the-place-of-death-in-patients-with-colorectal-cancer-analysis-of-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-of-9p21-deletions-on-chemotherapy-outcomes-in-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-dependent-antitumor-activity-of-hcb101-plus-ramucirumab-and-paclitaxel-in-previously-treated-ga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-extended-neoadjuvant-flot-for-resectable-gastroesophageal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conversion-chemotherapy-for-locally-advanced-pancreatic-carcinoma-folfirinox-or-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-minimal-residual-disease-detection-using-tumor-informed-circulating-tumor-dna-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/continued-zenocutuzumab-treatment-beyond-progression-in-patients-with-inrg1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-mfolfoxfiri-after-curative-intent-resection-of-oligometastatic-colorectal-cancer-phase-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonist-vs-aspirin-for-primary-prevention-of-colorectal-cancer-evidence-from-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-open-label-study-of-oral-s241656-bdtx-4933-as-monotherapy-and-in-combination-with-oth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-ctdna-in-patients-with-colorectal-cancer-and-liver-metastases-associations-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-sbrt-to-liver-and-portal-vein-tumor-thrombus-followed-by-immunotherapy-or-lenvatinib-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-of-day-administration-of-neoadjuvant-chemoradiotherapy-on-pathologic-complete-respons 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-5-fluorouracil-leucovorin-oxaliplatin-and-docetaxel-flot-administration-in-matterho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-dose-escalation-and-expansion-study-of-ryz401-a-novel-radiopharmaceutica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditional-survival-after-surgical-resection-of-well-differentiated-pancreatic-neuroendocrine-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-for-pembrolizumab-in-msi-high-msi-h-advanced-colorectal-cancer-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-determinants-of-ctdna-shedding-in-colorectal-cancer-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-sexual-health-and-post-treatment-issues-among-female-survivors-of-anal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/test-your-biomarkers-real-world-perspectives-and-patient-reported-outcomes-on-biomarker-testing-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toripalimab-plus-hepatic-artery-infusion-chemotherapy-in-hepatocellular-carcinoma-patients-of-barcel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-of-immunotherapy-combinations-for-first-line-treatment-in-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-combined-with-lenvatinib-versus-hepatic-artery-infusion-chemotherapy-haic-for-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-neoadjuvant-therapy-vs-standard-therapy-in-locally-advanced-rectal-cancer-a-single-center-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-clinical-presentation-of-early-onset-colorectal-cancer-constipation-as-a-novel-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adjuvant-mfolfox6-on-imaging-diagnosis-after-hepatectomy-for-colorectal-liver-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-clinical-correlates-of-alk-fusions-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-hospital-outcomes-of-splanchnic-vein-thrombosis-in-patients-with-gastrointestinal-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-the-prevalence-of-germline-pathogenic-variants-gpv-in-neuroendocrine-neoplasms-nens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-readmissions-identifying-high-risk-patients-and-drivers-of-cost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-folfirinox-for-locally-advanced-pancreatic-cancer-the-need-for-individualized-strategies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pyroptosis-and-gasdermin-expression-in-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-utility-of-geriatric-assessment-and-management-in-older-adults-with-cancer-from-evidence-to-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-proton-pump-inhibitors-and-antibiotics-on-survival-in-immunotherapy-treated-gastrointestin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-the-albumin-bilirubin-albi-score-and-ecog-performance-status-for-enhanced-prognosticatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-adjuvant-chemotherapy-on-prognosis-in-patients-with-familial-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-piwi-rna-signatures-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/data-driven-subtyping-and-differential-glufosfamide-benefit-in-pancreatic-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-regional-lymph-node-ratio-lnr-in-locally-advanced-gastric-cancer-a-single-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/procedure-specific-mortality-risk-in-octogenarians-undergoing-curative-gi-cancer-resection-a-contem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proximal-gastrectomy-versus-total-gastrectomy-in-locally-advanced-upper-gastric-cancer-after-neoadju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-first-line-immune-checkpoint-inhibitors-plus-chemotherapy-versus-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-unsupervised-visual-representation-learning-on-whole-slide-images-of-bile-duct-stricture 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-combination-therapy-with-anti-egfr-antibody-as-first-line-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-ii-study-of-fruquintinib-plus-sintilimab-as-a-second-line-therapy-for-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cdc-based-analysis-of-anal-cancer-mortality-disparities-in-us-adults-aged-65-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changing-landscape-of-multidisciplinary-management-in-locally-advanced-rectal-cancer-2015-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-trials-on-the-menu-a-patient-and-clinician-validated-plain-language-platform-for-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/s2408-a-randomized-phase-iii-blinded-trial-of-lanreotide-for-the-prevention-of-postoperative-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clarity-gastric-01-a-randomized-phase-3-study-of-sonesitatug-vedotin-sone-ve-a-claudin182-cldn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artemide-hcc01-a-phase-3-randomized-open-label-sponsor-blinded-multicentre-global-study-of-ril 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-analysis-of-the-juliet-trial-of-tisagenlecleucel-in-patients-with-relapsedrefractory-larg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-of-cohort-studies-assessing-flot-regimen-in-the-treatment-of-esophageal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-year-outcomes-and-multi-omics-biomarker-discovery-of-locally-advanced-esophageal-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-and-pirfenidone-in-combination-with-anti-pd-1-antibody-in-pmmrmss-metastatic-colorecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreastatin-as-a-predictive-biomarker-for-outcomes-with-peptide-receptor-radionuclide-therapy-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/idpydi-genotype-guided-dose-personalization-for-fluoropyrimidine-prescribin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-oxaliplatin-or-irinotecan-rechallenge-vs-standard-third-line-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-self-controlled-electroacupuncture-helmet-for-chemotherapy-induced-cognitive-impairment-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-chemotherapy-versus-preoperative-chemoradiation-therapy-in-gastroesophageal-adenocarci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-rate-of-msi-highdmmr-upper-and-lower-gi-cancers-to-neoadjuvant-immunotherapy-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-feasibility-analysis-to-align-fit-for-purpose-real-world-rw-data-to-emulate-the-azur-1-single-ar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-tas-102-with-or-without-celecoxib-in-ctdna-defined-minimal-residual-disease-mrd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-heterozygous-ugt1a128-genotype-on-toxicity-dose-intensity-and-treatment-compliance-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologic-outcomes-in-patients-undergoing-robotic-esophagectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-agent-system-for-automated-identification-of-competitive-clinical-trials-in-colorectal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diffuse-idiopathic-skeletal-hyperostosis-dish-and-gastrointestinal-system-cancer-a-mayo-clinic-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fit-as-a-cornerstone-of-crc-screening-optimization-for-advanced-neoplasia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-serial-ctdna-dynamics-to-predict-clinical-outcomes-in-metastatic-and-locally-advanced-pdac-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-associated-mutation-patterns-and-a-potential-therapeutic-opportunity-in-early-onset-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-understaging-in-early-gastric-cancer-a-common-and-significant-problem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-adapted-neoadjuvant-therapy-in-gastric-cancer-rant-gc-a-phase-ib-feasibility-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-adjuvant-toripalimab-in-stage-iib-iic-or-iii-colon-cancer-with-mismatch-repair-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modeling-analysis-of-rationale-305-impact-of-peritoneal-metastasis-pm-representation-on-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institutional-experience-on-patterns-of-ivermectin-and-fenbendazole-use-among-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-the-safety-lead-in-for-a-phase-1b2-study-of-ivosidenib-plus-durvalumab-and-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-institutional-retrospective-study-of-idh2-mutated-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-transarterial-chemoembolization-and-stereotactic-body-radiotherapy-followed-by-immunother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-large-language-models-llm-to-guide-adjuvant-chemotherapy-ac-recommendations-in-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-initial-corticosteroid-doses-and-second-line-immunosuppressants-on-overall-duration-of-cor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-randomized-study-comparing-telisotuzumab-adizutecan-monotherapy-with-standard-of-care-in-p-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/significance-of-atypical-peritoneal-cytology-in-patients-with-locally-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-yield-of-germline-genetic-testing-for-early-onset-colorectal-cancer-in-a-safety-net-healt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/us-gastrointestinal-malignancies-mortality-trends-among-asian-and-pacific-islander-populations-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-ierbb2i-her2-amplification-rna-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-exercise-and-nutritional-prehabilitation-on-preoperative-lean-body-mass-in-elderly-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-obesity-molecular-subtype-and-immunotherapy-outcomes-in-intrahepatic-cholangio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utility-of-histotype-px-colorectal-as-a-prognostic-and-potentially-predictive-biomarker 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-liquid-biomarkers-to-track-fibrotic-changes-in-pancreatic-cancer-patients-treated-with-combin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-liver-cancer-and-frailty-in-elderly-life-study-longitudinal-functional-status-analysis-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-liquid-biopsy-molecular-profiling-among-native-american-patients-with-pancreatic-ductal-adeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-tis-chemotherapy-ct-vs-placebo-pbo-ct-as-first-line-treatment-for-locally-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-chemoimmunotherapy-on-survival-in-stage-ii-iv-gastric-adenocarcinoma-an-ncdb-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-trifluridinetipiracil-bevacizumab-in-refractory-metastatic-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exposure-response-analyses-from-a-randomized-dose-optimization-study-of-telisotuzumab-adizutecan-te 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-efficacy-and-safety-of-imc002-a-vhh-based-anti-cldn182-car-t-therapy-for-gastroe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/magnetic-and-indocyanine-green-icg-sentinel-lymph-node-mapping-in-colorectal-cancer-a-feasibility 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-the-nectin2-tigit-axis-on-resistance-to-pd-l1-blockade-combined-with-chemoradiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-plus-chemoradiotherapy-crt-versus-crt-or-chemotherapy-ct-as-the-neoadjuvant-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-and-assessing-the-clinical-effectiveness-of-deep-inspiration-breath-hold-compared-to-free 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-readmission-and-readmission-related-mortality-in-older-adults-with-pancreatic-adenocar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-biomarkers-of-systemic-treatment-in-pancreatic-ductal-adenocarcinoma-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adebrelimab-with-or-without-induction-chemotherapy-followed-by-concurrent-chemoradiotherapy-for-unre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreatic-cancer-and-coexisting-diabetes-survival-outcomes-from-a-provincial-canadian-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-combined-with-trifluridinetipiracil-versus-regorafenib-monotherapy-in-refractory-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-trends-in-gi-cancer-demographic-and-socioeconomic-influences 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-elderly-patients-with-advanced-pancreatic-ductal-adenocarcinoma-utilizing-a-metronomic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-risk-factors-of-non-neutropenic-enterocolitis-with-adjuvant-capecitabine-and-oxaliplat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-configurations-and-liver-niche-drive-tumor-intrinsic-state-plasticity-in-metastatic-mss-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/matching-adjusted-indirect-comparison-of-fruquintinib-versus-ramucirumab-in-advanced-gastric-or-gast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiofrequency-ablation-versus-stereotactic-body-radiation-therapy-for-early-stage-hepatocellular-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-stratified-iraes-with-immune-checkpoint-inhibitors-in-patients-with-metastatic-gastric-and-color 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-ferric-carboxymaltose-on-anemia-in-patients-with-gastrointestinal-cancer-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-molecular-clinico-pathological-and-outcome-differences-between-early-onset-eo-lt50-ye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-transcriptomic-predictors-of-early-vs-late-recurrence-after-curative-intent-surgery-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-distal-gastrectomy-be-considered-a-treatment-option-for-localized-type-4-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-pancreatic-parenchymal-fibrosis-on-long-term-outcomes-in-pancreatic-cancer-patients-measur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-adjuvant-and-perioperative-systemic-therapies-in-gastric-and-gastroesophageal-junction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/closing-the-documentation-gap-cdi-physician-advisor-education-and-its-effect-on-quality-metrics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-of-futibatinib-vs-pemigatinib-in-metastatic-cholangiocarcinoma-faers-based-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tmac-trial-a-randomized-single-blinded-sham-controlled-study-evaluating-effectiveness-of-repetiti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advanced-pancreatic-adenocarcinoma-outcomes-in-patients-with-ddr-deficiencies-outside-of-brca12-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-morphomics-and-metabolomics-as-metastatic-pancreatic-cancer-prognosticators 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-multicenter-study-of-zw251-a-novel-glypican-3-gpc3-targeted-antibody-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-chemotherapy-with-docetaxel-oxaliplatin-and-s-1-for-gastric-cancer-with-extensive-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distribution-of-driver-and-allele-specific-kras-mutations-across-racial-and-ethnic-groups-in-pancrea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-modified-gemcitabinenab-paclitaxel-schedules-in-first-line-therapy-for-advanced-pancr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-randomized-global-trial-to-investigate-efficacy-and-safety-of-epcam-4-1bb-bsab-bnt3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-hrd-status-and-arid1a-expression-in-individual-gastrointestinal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-circulating-tumor-dna-ctdna-to-monitor-patients-undergoing-total-neoadjuvant-treatment-tnt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-optimal-detection-of-imtapi-homozygous-loss 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-vs-lenvatinib-or-sorafenib-as-first-line-treatment-for-unresectable-hepato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/idpydi-testing-in-gi-cancers-a-real-world-analysis-of-costs-and-quality-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-results-of-sup212sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-journey-for-participants-pts-in-the-matterhorn-trial-a-global-randomized-phase-3-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-retifanlimab-in-gastrointestinal-malignancies-a-systematic-review-of-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5-fu-freedom-patient-perspectives-from-colontown-on-the-practice-of-pump-self-disconnect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-liver-function-on-survival-outcomes-in-patients-pts-treated-with-first-line-atezolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthful-plant-based-diet-index-hpdi-and-risk-of-upper-gastrointestinal-cancer-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-multidisciplinary-management-of-hcc-with-cirrhosis-in-community-based-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-residual-disease-detection-using-whole-genome-sequencing-based-ctdna-assay-for-resectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/which-patients-with-colorectal-cancer-develop-brain-metastases-a-multicenter-analysis-of-clinical-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-combination-immunotherapy-in-patients-with-child-pugh-class-b-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-on-the-impact-of-glp-1-receptor-agonists-on-survival-and-metastatic-risk-in-colo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutational-analysis-and-identification-of-potential-biomarkers-in-patients-with-metastatic-pancreati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redefining-the-use-of-a-first-line-folfirinox-like-regimen-in-older-patients-with-metastatic-pancrea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-versus-local-ablation-therapy-for-the-treatment-of-hepatocellular-carcinoma-a-systemat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-first-line-chemotherapy-in-elderly-patients-with-advanced-biliary-tract-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-penpulimab-a-pd-1-inhibitor-anlotinib-an-antiangiogenic-targeted-drug-nab-paclitaxe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-ctdna-in-early-switch-of-first-line-mfolfirinox-in-metastatic-pancreatic-ductal-adenocarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-characterization-of-biliary-tract-cancer-patients-from-the-spanish-retud-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-serum-tumor-marker-dynamics-during-preoperative-chemotherapy-and-hepatectom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-center-phase-1b2-clinical-trial-of-concurrent-administration-of-fruquintinib-and-ftdtpi-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantification-of-circulating-tumor-dna-ctdna-using-a-methylation-based-tissue-free-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-readmission-drivers-in-right-versus-left-sided-colorectal-cancer-insights 2026-08-24 monthly 0.7 https://rjrindex.com/articles/source-matters-performance-of-guideline-anchored-rag-versus-broad-evidence-llms-in-gi-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-enhanced-biomarker-analysis-of-wnt-tgf-v-and-pi3k-pathway-alterations-in-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-robot-assisted-surgery-on-postoperative-sexual-function-in-younger-male-rectal-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-multiomics-on-tumor-microenvironment-remodeling-in-locally-advanced-rectal-cancer-follo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/activity-of-dem301-a-novel-anti-dem-txx-antibody-drug-conjugate-for-the-treatment-of-gastrointestin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bmi-at-diagnosis-and-pre-diagnosis-weight-loss-as-predictors-of-stage-and-survival-in-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conversion-surgery-for-stage-iv-gastric-cancer-real-world-insights-with-a-focus-on-elderly-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditional-recurrence-free-survival-after-curative-resection-of-esophageal-cancer-integrated-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-her2-expression-in-advanced-hepatocellular-carcinoma-using-tumor-biopsy-samples 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-robotic-vs-laparoscopic-liver-resection-for-bclc-stage-0-i-hepatocellular-carcinoma-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreatic-metastases-from-small-cell-lung-cancer-systematic-review-of-clinical-presentation-diagn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institutional-analysis-of-missed-opportunities-in-lynch-syndrome-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-with-the-ice-regimen-in-refractory-rasbraf-wild-type-and-mss-mcrc-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-controlled-phase-ii-trial-comparing-nivolumab-ipilimumab-plus-radiotherapy-versus-nivolu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-consensus-molecular-subtype-classification-of-colorectal-cancer-using-preoperative-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-regimen-selection-systemic-therapy-completion-and-host-determinants-as-predictors-in-localiz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-blood-biomarker-test-for-early-detection-of-pancreatic-ductal-adenocarcinoma-pdac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precemtabart-tocentecan-precem-tct-m9140-in-patients-with-mcrc-efficacy-and-safety-data-at-the-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-a-computational-histology-artificial-intelligence-powered-predictive-biomarker-for-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-pembrolizumab-for-participants-with-hepatocellular-carcinoma-and-complete-radiologic-respon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-perioperative-and-neoadjuvant-therapies-including-immunotherapy-in-resectable-gastroesop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-codon-level-kras-mutations-on-response-to-tas-102-tas-102bevacizumab-or-regorafenib-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-short-course-radiotherapy-combined-with-capox-and-pd-1-inhibitor-for-msspmmr-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-ikrasi-exon-3-exon-4-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-and-biomarker-analysis-of-cldn182-targeted-adc-combined-with-the-net-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/jaguar-jaccro-pm-01-a-prospective-study-to-evaluate-the-clinical-utility-of-serial-comprehensive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-potential-new-biomarker-for-enhanced-molecular-imaging-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-enabled-precision-oncology-in-early-onset-colorectal-cancer-molecular-chara 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biliary-tract-carcinoma-real-world-evidence-in-a-developing-country 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retreatment-patterns-and-outcomes-in-patients-pts-with-gastroenteropancreatic-neuroendocrine-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-treatment-patterns-by-specific-metastatic-sites-in-stage-iv-colon-cancer-a-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durable-responses-to-immunotherapy-in-dmmrmsi-h-metastatic-colorectal-cancer-patients-with-poor-per 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-analysis-of-patients-with-colorectal-cancer-in-ireland 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-arm-phase-2-study-of-the-fgfr-inhibitor-futibatinib-futi-in-combination-with-pembrolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-based-outcomes-and-patterns-of-care-of-patients-with-metastatic-pancreatic-cancer-an-updated-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-sintilimab-plus-capecitabine-in-resected-extrahepatic-cholangiocarcinoma-interim-report-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-tolerability-of-all-trans-retinoic-acid-bevacizumab-and-atezolizumab-in-refractory-micr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-first-in-human-open-label-multicenter-study-of-bi3706674-kras-multi-inhibitor-monother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-evaluation-of-asp3082-a-first-in-class-selective-protein-degrader-in-patients-pts-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-palliative-care-and-clinical-outcomes-in-gastric-cancer-with-sepsis-a-population-based-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/readability-and-quality-of-information-of-ai-generated-patient-education-materials-on-familial-adeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-transcriptomic-analysis-of-early-and-late-onset-colorectal-cancer-across-tcga-geo-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-the-sequencing-and-timing-of-transarterial-chemoembolization-and-systemic-therapy-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tas-102-plus-bevacizumab-in-refractory-metastatic-colorectal-cancer-a-systematic-review-and-meta-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-immunomodulatory-low-dose-radiotherapy-plus-chemoimmunotherapy-as-conversion-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-dietitian-follow-up-after-pancreatectomy-and-post-operative-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-dcf-plus-nivolumab-versus-induction-dcf-for-unresectable-locally-advanced-esophageal-squam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-claudin-1-cldn1-expression-on-molecular-correlates-and-clinical-outcomes-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-dpyd-variants-across-ancestries-in-a-large-real-world-cohort-of-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isocitrate-dehydrogenase-1-mutations-in-biliary-tract-cancer-patients-in-spanish-retud-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disco-diagnostic-performance-of-sup64sup-cu-sartate-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-y220c-mutation-in-esophageal-adenocarcinoma-a-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-fruquintinib-and-trifluridinetipiracil-to-improve-outcomes-in-the-real-world-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-correlation-between-clonal-hematopoiesis-and-response-to-regorafenib-and-nivolumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-therapeutic-targeting-of-xct-on-usp15smad-driven-gemcitabine-resistance-in-kras-mutant-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-imtapi-loss-in-liquid-biopsies-from-patients-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemo-immunotherapy-sequential-with-radiotherapy-and-immunotherapy-consolidation-in-patients-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoradiotherapy-versus-chemotherapy-alone-for-locally-advanced-esophageal-adenocarcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/generalized-applicability-of-da-vinci-sp-for-gastrectomy-considering-from-short-term-outcomes-learn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-ppv-of-sup18sup-ffapi-74-pet-to-identify-fap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atezolizumab-with-bevacizumab-and-nonplatinum-chemotherapy-for-recurrent-ovarian-cancer-final-resul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-care-and-access-to-resources-in-neuroendocrine-tumors-nets-a-cross-sectional-survey-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-hepatocellular-carcinoma-outcomes-by-distance-insurance-and-treatment-access-a-10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-structural-variant-based-ctdna-detection-of-mrd-in-colorectal-cancer-the-citcca-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gallbladder-and-bile-duct-cancer-a-us-mortality-overview 2026-08-24 monthly 0.7 https://rjrindex.com/articles/number-needed-to-treatharm-nntnnh-a-benefitrisk-analysis-of-fruquintinib-vs-other-treatments-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-first-line-immune-checkpoint-inhibitor-combinations-in-advanced-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-liver-directed-therapy-on-survival-in-patients-with-colon-cancer-and-isolated-hepatic-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-neurotoxicity-patterns-across-neuroendocrine-tumor-grades-a-real-world-analysis-of-12 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-patient-attrition-across-the-colorectal-cancer-screening-pathway-insights-from-a-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-age-stage-and-social-vulnerability-index-with-colon-cancer-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-to-guide-rechallenge-with-cetuximab-plus-irinotecan-in-chinese-rasbraf-wild-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trifluridinetipiracil-plus-ramucirumab-in-advanced-gastric-cancer-as-third-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-homologous-recombination-deficiency-signature-in-esophageal-and-gastric-adenoca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spliceosome-driven-transcriptomic-profiling-to-reveal-prognostic-subtypes-and-risk-stratification-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pathological-complete-response-after-dcf-neoadjuvant-chemotherapy-followed-by-surgery-on-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-receptor-agonists-and-the-risk-of-developing-malignancies-of-the-liver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-run-in-results-from-c-solve-jaccro-gc-12-a-randomized-non-comparative-phase-ii-trial-of-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emerging-radiation-paradigms-utilization-and-survival-outcomes-of-brachytherapy-vs-ebrt-in-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-fulvestrant-in-combination-with-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kandlelit-012-phase-3-study-of-mk-1084-a-ikras-g12ci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-combined-with-folfirinox-and-bevacizumab-as-first-line-treatment-for-microsatellite-stab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-claims-based-machine-learning-to-assign-pancreatic-cancer-stage-for-enhanced-outcomes-researc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fecal-microbiota-transplantation-fmt-combined-with-first-line-gemcitabine-and-nab-paclitaxel-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-the-idylla-cdx-msi-test-in-identifying-msi-h-mcrc-patients-eligible-for-nivoluma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastrointestinal-malignancies-in-syria-an-epidemiological-analysis-from-the-countrys-main-cancer-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonist-use-and-pancreatic-cancer-risk-in-patients-with-chronic-pancreatitis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-study-of-rp2-oncolytic-immunotherapy-expressing-anti-ctla-4-in-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-biomarker-testing-in-patients-with-metastatic-colorectal-cancer-through-patient-education 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-folfox-vs-folfiri-as-second-line-therapy-in-metastatic-biliary-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-free-rna-cfrna-as-a-predictive-tool-for-immunotherapy-benefit-in-mismatch-repair-defic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-capecitabine-and-temozolomide-captem-in-patients-with-gastrointestinal-neuroendocrine 2026-08-24 monthly 0.7